Phenobarbital in the perinatal period.
D000818:Animals; D000831:Animals, Newborn / Q000187:drug effects; D001663:Bilirubin / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury; D004336:Drug Antagonism; D004357:Drug Synergism; D004790:Enzyme Induction / Q000187:drug effects; D005246:Feedback; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy; D007226:Infant Mortality; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control; D007567:Jaundice, Neonatal; D008099:Liver / Q000201:enzymology; D010634:Phenobarbital / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011247:Pregnancy / Q000187:drug effects*; D051381:Rats; D013256:Steroids / Q000378:metabolism
D013256:Steroids; D001663:Bilirubin; D010634:Phenobarbital